An insulin pump therapy device

Abstract

A spectral online blood glucose analyzer and an insulin pump control method relate to an insulin pump therapeutic apparatus for diabetic patients. It is mainly invented to solve the problem that the existing insulin pump can only reflect the blood sugar situation at the time of blood collection and cannot measure the blood sugar level continuously. Using spectral online analysis technology, the blood glucose concentration in the human body is analyzed and measured online in vitro. According to the continuous and uninterrupted detection and analysis data of the online analyzer, combined with artificial intelligence systems such as telemedicine support, the insulin infusion dose is adjusted and the treatment plan is optimized. Through the wireless data network, the above data is transmitted to the central module, the central module controls the program controller PLC, and then the PLC controls the operation of the insulin pump. Insulin pump, insulin storage bottle and program controller PLC are integrated in a portable box, and there are two or more insulin storage bottles in the box.

Description

technical field [0001] The invention relates to an insulin pump therapeutic apparatus used by diabetic patients. Background technique [0002] Diabetes is a serious chronic disease that is harmful to the population. It is one of the four major non-communicable diseases identified by the World Health Organization. The incidence rate is increasing year by year, and the growth rate is accelerating. Acute and chronic complications of diabetes, especially chronic complications, can affect almost all organs of the human body, with high self-mutilation and fatality rates, greatly affecting the quality of life and life expectancy of patients, and bringing a heavy burden to the family and society. [0003] To improve clinical outcomes for patients with diabetes, the principles of early, long-term, comprehensive, and individualized treatment are currently emphasized. The goal of treatment is to make the patient's blood sugar reach or close to normal levels, eliminate glucotoxicity an...

AI Technical Summary

Problems solved by technology

But this method also has defects and deficiencies: 1. After the patient purchases the insulin pump, he needs to take blood under the skin continuously for a period of one week, and analyze the blood sugar content (manually), and then formulate the control of the amount of insulin infusion according to the blood sugar analysis measurement results Model

Its defect is that the model can only reflect the blood sugar changes during the blood collection period, and cannot represent the blood sugar changes in the future period, which has limitations and blindness, and continuous blood collection increases the risk of infection and pain for patients

2. In order to correct blood sugar change data, this method provides a portable blood glucose meter, but the patient can only take blood intermittently with test strips and insert the blood glucose meter for detection, and it can only reflect the blood sugar situation at the time of blood collection, and cannot continuously measure blood sugar levels , cannot fully simulate physiological insulin secretion, and cannot effectively avoid peripheral hyperinsulinemia, diabetic ketoacidosis and hypoglycemia

3. High requirements for users and high price

Images